Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 12”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Testing effectiveness (Phase 2)Study completedNCT02471196
What this trial is testing

Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Orion Corporation, Orion Pharma 308
Large-scale testing (Phase 3)Study completedNCT01047254
What this trial is testing

Bupropion for the Treatment of Apathy in Alzheimer's Dementia

Who this might be right for
Apathy in Dementia
University Hospital, Bonn 110
Not applicableUnknownNCT03288363
What this trial is testing

Transcranial Direct Current Stimulation and Early Alzheimer's Disease (tDCS-AD)

Who this might be right for
Alzheimer Disease
Benjamin CALVET 80
Post-approval studies (Phase 4)Study completedNCT01841125
What this trial is testing

Escitalopram for the Treatment of Depression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Konkuk University Medical Center 84
Large-scale testing (Phase 3)Study completedNCT03446001
What this trial is testing

Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment

Who this might be right for
Alzheimer Disease
TauRx Therapeutics Ltd 598
Not applicableStudy completedNCT04771845
What this trial is testing

Transcranial Magnetic Stimulation in Mild Cognitive Impairment and Alzheimer Disease

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
The New York Memory Services 73
Testing effectiveness (Phase 2)Study completedNCT00501111
What this trial is testing

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AstraZeneca 659
Large-scale testing (Phase 3)Looking for participantsNCT06534723
What this trial is testing

Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)

Who this might be right for
Alzheimer's Dementia
Sichuan Jishengtang Pharmaceutical Co., Ltd. 570
Post-approval studies (Phase 4)WithdrawnNCT00711204
What this trial is testing

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

Who this might be right for
Severe Alzheimer's Disease
Eisai Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06362707
What this trial is testing

Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

Who this might be right for
Cognitive Decline, MildAlzheimer Disease
Helse Stavanger HF 200
Large-scale testing (Phase 3)Ended earlyNCT05169008
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents

Who this might be right for
COVID-19
CanSino Biologics Inc. 91
Not applicableStudy completedNCT03622905
What this trial is testing

ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Functional Neuromodulation Ltd 74
Post-approval studies (Phase 4)Active Not RecruitingNCT07034222
What this trial is testing

12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease(AD)
Ruijin Hospital 80
Testing effectiveness (Phase 2)Study completedNCT02727699
What this trial is testing

A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)

Who this might be right for
Dementia, Alzheimer Type
Actinogen Medical 185
Large-scale testing (Phase 3)Study completedNCT01862640
What this trial is testing

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 433
Large-scale testing (Phase 3)Study completedNCT00829374
What this trial is testing

Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 1,003
Testing effectiveness (Phase 2)Ended earlyNCT02249351
What this trial is testing

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 54
Large-scale testing (Phase 3)Study completedNCT03594123
What this trial is testing

A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 259
Not applicableWithdrawnNCT04100889
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+20 more
ProgenaBiome
Large-scale testing (Phase 3)Ended earlyNCT02586909
What this trial is testing

12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension

Who this might be right for
Alzheimer's Disease
Axovant Sciences Ltd. 1,099
Load More Results